3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
2
Terminated
1
Recruiting
1
Not yet recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Pancreatic Neoplasms
9
Carcinoma, Non-Small-Cell Lung
7
Rectal Neoplasms
6
Colorectal Neoplasms
6
Breast Neoplasms
6
Neoplasms
5
Glioblastoma
5
Squamous Cell Carcinoma of Head and Neck
4
Ovarian Neoplasms
4
Head and Neck Neoplasms
4
Stomach Neoplasms
3
Oligodendroglioma
3
Mouth Neoplasms
3
Lung Neoplasms
3
Glioma
3
Esophageal Neoplasms
3
Astrocytoma
3
Urinary Bladder Neoplasms
2
Sarcoma
2
Neoplasm Metastasis
2
Meningioma
2
Melanoma
2
Gliosarcoma
2
Glioma, Subependymal
2
Fallopian Tube Neoplasms
2
Ependymoma
2
Carcinoma, Squamous Cell
2
Carcinoma, Ovarian Epithelial
2
Adenocarcinoma Of Esophagus
2
Xerostomia
1
Interventions
pembrolizumab
20
Carboplatin
14
Cyclophosphamide
12
atezolizumab
11
Paclitaxel
10
Albumin-Bound Paclitaxel
8
Capecitabine
7
Nivolumab
6
130-nm albumin-bound paclitaxel
6
spartalizumab
5
fludarabine
5
Taxes
5
Gemcitabine
5
talazoparib
4
bintrafusp alfa protein, human
4
avelumab
4
Cisplatin
4
sacituzumab govitecan
3
olaparib
3
entinostat
3
Leucovorin
3
Ipilimumab
3
Immunoglobulin G
3
Drug Therapy
3
Doxorubicin
3
Docetaxel
3
Biopsy
3
2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide
3
trilaciclib
2
eribulin
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Triple Negative Breast Neoplasms
×
Surgical Procedures, Operative
×
Clear all
NCT04770272
2026-01-12
neoMono
Palleos Healthcare GmbH
Phase 2
Terminated
442 enrolled
42 charts